Dr. Larry Norton
Larry Norton, MD, FASCO, FAACR is Senior Vice President in the Office of the President, Medical Director of the Evelyn H. Lauder Breast Center, and the Norna S. Sarofim Chair of Clinical Oncology in Memorial Sloan Kettering, New York. He is also a Professor of Medicine, Weill Medical College of Cornell University, an Adjunct Professor at the Cold Spring Harbor laboratory, and a Member of the MIT Laboratory for Financial Engineering. Dr. Norton is the Founding Scientific Director of the Breast Cancer Research Foundation. He has served on or chaired numerous committees of the National Cancer Institute, National Institutes of Health, and the Institute of Medicine of the National Academy of Sciences (now National Academy of Medicine) and has served as President of the American Society of Clinical Oncology among other leadership roles.
Dr. Norton has dedicated his life to the eradication of cancer by activities in medical care, laboratory and clinical research, advocacy, journal editing, and government. His research is broad, but he is best known for mathematical modeling in therapeutic (including paclitaxel and trastuzumab) and diagnostic (including BRCA1) development. He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and the self-seeding concept of cancer metastasis and growth. He has been the Principal Investigator of a highly productive NCI Program Project Grant in Models of Human Breast Cancer, has authored more than 430 published articles and many book chapters, and has trained dozens of oncologists, many of whom are now in leadership positions.
Among many honors, he received ASCO’s Karnofsky and Bonadonna Awards, the McGuire Lectureship at the San Antonio Breast Cancer Symposium, MSK's Whitmore Award for Clinical Excellence, the Columbia University’s Gold Medal for Outstanding Achievement in Medical Research, the Thomson Reuters Highly Cited Researcher Certificate, the Susan G. Komen Foundation’s Scientific Achievement and Brinker Awards, the BCRF’s Rose Award, the Cold Spring Harbor Double Helix Medal, and election to the American Academy of Arts and Sciences.
Dr. Norton has dedicated his life to the eradication of cancer by activities in medical care, laboratory and clinical research, advocacy, journal editing, and government. His research is broad, but he is best known for mathematical modeling in therapeutic (including paclitaxel and trastuzumab) and diagnostic (including BRCA1) development. He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and the self-seeding concept of cancer metastasis and growth. He has been the Principal Investigator of a highly productive NCI Program Project Grant in Models of Human Breast Cancer, has authored more than 430 published articles and many book chapters, and has trained dozens of oncologists, many of whom are now in leadership positions.
Among many honors, he received ASCO’s Karnofsky and Bonadonna Awards, the McGuire Lectureship at the San Antonio Breast Cancer Symposium, MSK's Whitmore Award for Clinical Excellence, the Columbia University’s Gold Medal for Outstanding Achievement in Medical Research, the Thomson Reuters Highly Cited Researcher Certificate, the Susan G. Komen Foundation’s Scientific Achievement and Brinker Awards, the BCRF’s Rose Award, the Cold Spring Harbor Double Helix Medal, and election to the American Academy of Arts and Sciences.